Literature DB >> 23660723

Laparoscopic total gastrectomy and gastric cancer genome architecture: lessons, cautions, and promises.

Christof Hottenrott1.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23660723     DOI: 10.1007/s00464-013-2988-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


× No keyword cloud information.
  32 in total

1.  Spatiotemporal individual genome code-lifestyle network: revolutionizing personal diagnostics.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2012-04       Impact factor: 5.225

2.  Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancer.

Authors:  Dimitrios H Roukos
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

3.  Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends.

Authors:  Christos G Katsios; George Baltogiannis; Dimitrios H Roukos
Journal:  Expert Rev Anticancer Ther       Date:  2010-04       Impact factor: 4.512

4.  Short-term surgical outcomes and operative risks of laparoscopic total gastrectomy (LTG) for gastric carcinoma: experience at a large-volume center.

Authors:  Oh Jeong; Seong Yeop Ryu; Xue-Feng Zhao; Mi Ran Jung; Kwang Yong Kim; Young Kyu Park
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

Review 5.  Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.

Authors:  D H Roukos
Journal:  Pharmacogenomics J       Date:  2010-10-26       Impact factor: 3.550

6.  Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes.

Authors:  Theodore Liakakos; Dimitrios H Roukos
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

7.  'Big' science: genome regulatory networks and novel molecular tools to improve health.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2011-03       Impact factor: 5.225

8.  Measurable evidence of miRNAs as regulators of cancer networks and therapeutic targets.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Med Devices       Date:  2011-03       Impact factor: 3.166

9.  Networks medicine: from reductionism to evidence of complex dynamic biomolecular interactions.

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2011-05       Impact factor: 2.533

10.  Cancer genome explosion and systems biology: impact on surgical oncology?

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2011-01       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.